UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 578

Sortiert nach

Clinical Characteristics and Outcomes of COVID-19–Infected Cancer Patients: A Systematic Review and Meta-Analysis

JNCI : Journal of the National Cancer Institute, 2021-04, Vol.113 (4), p.371-380

2021

Volltextzugriff (PDF)

Intron retention is a source of neoepitopes in cancer

Nature biotechnology, 2018-12, Vol.36 (11), p.1056-1058

2018

Volltextzugriff (PDF)

The Myeloma Drug Lenalidomide Promotes the Cereblon-Dependent Destruction of Ikaros Proteins

Science (American Association for the Advancement of Science), 2014-01, Vol.343 (6168), p.305-309

2014

Volltextzugriff (PDF)

Targeting the PI3K signaling pathway in cancer

Current opinion in genetics & development, 2010-02, Vol.20 (1), p.87-90

2010

Volltextzugriff (PDF)

False positive plasma genotyping due to clonal hematopoiesis

Clinical cancer research, 2018-09, Vol.24 (18), p.4437-4443

2018

Volltextzugriff (PDF)

Autophagy Sustains Pancreatic Cancer Growth through Both Cell-Autonomous and Nonautonomous Mechanisms

Cancer discovery, 2018-03, Vol.8 (3), p.276-287

2018

Volltextzugriff (PDF)

Recent advances in preclinical models for lung squamous cell carcinoma

Oncogene, 2021-04, Vol.40 (16), p.2817-2829

2021

Volltextzugriff (PDF)

Targeting glutamine-addiction and overcoming CDK4/6 inhibitor resistance in human esophageal squamous cell carcinoma

Nature communications, 2019-03, Vol.10 (1), p.1296-15, Article 1296

2019

Volltextzugriff (PDF)

Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints

Nature communications, 2016-02, Vol.7 (1), p.10501-10501, Article 10501

2016

Volltextzugriff (PDF)

Activation of Oxidative Stress Response in Cancer Generates a Druggable Dependency on Exogenous Non-essential Amino Acids

Cell metabolism, 2020-02, Vol.31 (2), p.339-350.e4

2020

Volltextzugriff (PDF)

Profound Tissue Specificity in Proliferation Control Underlies Cancer Drivers and Aneuploidy Patterns

Cell, 2018-04, Vol.173 (2), p.499-514.e23

2018

Volltextzugriff (PDF)

Targeting HER2 Aberrations in Non-Small Cell Lung Cancer with Osimertinib

Clinical cancer research, 2018-06, Vol.24 (11), p.2594-2604

2018

Volltextzugriff (PDF)

ER Stress Signaling Promotes the Survival of Cancer "Persister Cells" Tolerant to EGFR Tyrosine Kinase Inhibitors

Cancer research (Chicago, Ill.), 2018-02, Vol.78 (4), p.1044-1057

2018

Volltextzugriff (PDF)

A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations

Cell, 2010-04, Vol.141 (1), p.69-80

2010

Volltextzugriff (PDF)

Prostate cancer-associated SPOP mutations confer resistance to BET inhibitors through stabilization of BRD4

Nature medicine, 2017-09, Vol.23 (9), p.1063-1071

2017

Volltextzugriff (PDF)

T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP

Proceedings of the National Academy of Sciences - PNAS, 2008-02, Vol.105 (6), p.2070-2075

2008

Volltextzugriff (PDF)

Interplay between Notch1 and Notch3 promotes EMT and tumor initiation in squamous cell carcinoma

Nature communications, 2017-11, Vol.8 (1), p.1758-16, Article 1758

2017

Volltextzugriff (PDF)

Bi-steric mTORC1 inhibitors induce apoptotic cell death in tumor models with hyperactivated mTORC1

The Journal of clinical investigation, 2023-11, Vol.133 (21), p.1-16

2023

Volltextzugriff (PDF)

In Vivo Epigenetic CRISPR Screen Identifies Asf1a as an Immunotherapeutic Target in Kras -Mutant Lung Adenocarcinoma

Cancer discovery, 2020-02, Vol.10 (2), p.270-287

2020

Volltextzugriff (PDF)

Loss of Smad4 promotes aggressive lung cancer metastasis by de-repression of PAK3 via miRNA regulation

Nature communications, 2021-08, Vol.12 (1), p.1-11, Article 4853

2021

Volltextzugriff (PDF)

Combined EGFR/MEK Inhibition Prevents the Emergence of Resistance in EGFR-Mutant Lung Cancer

Cancer discovery, 2015-09, Vol.5 (9), p.960-971

2015

Volltextzugriff (PDF)

BORIS promotes chromatin regulatory interactions in treatment-resistant cancer cells

Nature (London), 2019-08, Vol.572 (7771), p.676-680

2019

Volltextzugriff (PDF)

EZH2-Mediated Primary Cilium Deconstruction Drives Metastatic Melanoma Formation

Cancer cell, 2018-07, Vol.34 (1), p.69-84.e14

2018

Volltextzugriff (PDF)

Activation of the PD-1 pathway contributes to immune escape in EGFR-driven lung tumors

Cancer discovery, 2013-12, Vol.3 (12), p.1355-1363

2013

Volltextzugriff (PDF)

1 – 25 von 578

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(531)
Mit Volltextzugriff
(535)

Publikationsform

Sprache

Englisch
(575)
Japanisch
(140)

Erscheinungsjahr

n.n

Thema

Science & Technology
(367)
Life Sciences & Biomedicine
(301)
Humans
(265)
Animals
(211)
Mice
(193)
Oncology
(173)
Cell Line, Tumor
(115)
Mutation
(103)
Lung Neoplasms - Genetics
(101)
Tumors
(96)
Lung Neoplasms - Drug Therapy
(81)
Female
(80)
Lung Cancer
(79)
Cell Biology
(77)
Male
(67)
Lung Neoplasms - Pathology
(66)
Cancer
(61)
Science & Technology - Other Topics
(57)
Multidisciplinary Sciences
(56)
Carcinoma, Non-Small-Cell Lung - Genetics
(54)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Cancer Research
(89)
Cancer Discovery
(30)
The Journal Of Clinical Investigation
(30)
Cancer Cell
(27)
Clinical Cancer Research
(24)
Nature
(22)
Proceedings Of The National Academy Of Sciences - Pnas
(19)
Plos One
(17)
Molecular Cancer Therapeutics
(15)
Nature Medicine
(14)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Clinical Characteristics and Outcomes of COVID-19–Infected Cancer Patients: A Systematic Review and Meta-Analysis

Intron retention is a source of neoepitopes in cancer

The Myeloma Drug Lenalidomide Promotes the Cereblon-Dependent Destruction of Ikaros Proteins

Targeting the PI3K signaling pathway in cancer

False positive plasma genotyping due to clonal hematopoiesis

Autophagy Sustains Pancreatic Cancer Growth through Both Cell-Autonomous and Nonautonomous Mechanisms

Recent advances in preclinical models for lung squamous cell carcinoma

PD-L1 engagement on T cells promotes self-tolerance and suppression of neighboring macrophages and effector T cells in cancer

Targeting glutamine-addiction and overcoming CDK4/6 inhibitor resistance in human esophageal squamous cell carcinoma

Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints

Activation of Oxidative Stress Response in Cancer Generates a Druggable Dependency on Exogenous Non-essential Amino Acids

Profound Tissue Specificity in Proliferation Control Underlies Cancer Drivers and Aneuploidy Patterns

Targeting HER2 Aberrations in Non-Small Cell Lung Cancer with Osimertinib

ER Stress Signaling Promotes the Survival of Cancer "Persister Cells" Tolerant to EGFR Tyrosine Kinase Inhibitors

A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations

Prostate cancer-associated SPOP mutations confer resistance to BET inhibitors through stabilization of BRD4

T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP

Interplay between Notch1 and Notch3 promotes EMT and tumor initiation in squamous cell carcinoma

Bi-steric mTORC1 inhibitors induce apoptotic cell death in tumor models with hyperactivated mTORC1

In Vivo Epigenetic CRISPR Screen Identifies Asf1a as an Immunotherapeutic Target in Kras -Mutant Lung Adenocarcinoma

Loss of Smad4 promotes aggressive lung cancer metastasis by de-repression of PAK3 via miRNA regulation

Combined EGFR/MEK Inhibition Prevents the Emergence of Resistance in EGFR-Mutant Lung Cancer

BORIS promotes chromatin regulatory interactions in treatment-resistant cancer cells

EZH2-Mediated Primary Cilium Deconstruction Drives Metastatic Melanoma Formation

Activation of the PD-1 pathway contributes to immune escape in EGFR-driven lung tumors

Suchergebnisse filtern